Core--Protocol review &monitoring system

$0P30FY2000CANIH

University Of Nebraska Medical Center, Omaha NE

Investigators

Linked publications, trials & patents

Paper 39684445 Paper 39678719 Paper 39605468 Paper 39580490 Paper 39573886 Paper 39456534 Paper 39450301 Paper 39436320 Paper 39420209 Paper 39386613 Paper 39386448 Paper 39384153 Paper 39339419 Paper 39224072 Paper 39219576 Paper 39151112 Paper 39141488 Paper 39130636 Paper 39125017 Paper 39110778 Paper 39107463 Paper 39080401 Paper 39013847 Paper 38974465 Paper 38969056 Paper 38946943 Paper 38900505 Paper 38853862 Paper 38847506 Paper 38775157 Paper 38770637 Paper 38733583 Paper 38712184 Paper 38704607 Paper 38687198 Paper 38683788 Paper 38672426 Paper 38617282 Paper 38603627 Paper 38547055 Paper 38542184 Paper 38514303 Paper 38482976 Paper 38445903 Paper 38437585 Paper 38429478 Trial NCT03226418 Trial NCT03073785 Trial NCT02874404 Trial NCT02833701 Trial NCT02654119 Trial NCT02561273 Trial NCT02553447 Trial NCT02168270 Trial NCT01959672 Trial NCT01825603 Trial NCT01750073 Trial NCT01555632 Trial NCT01431209 Trial NCT01336933 Trial NCT01336920 Trial NCT01307956 Trial NCT01106898 Trial NCT01093183 Trial NCT01068327 Trial NCT01044745 Trial NCT01035463 Trial NCT00959244 Trial NCT00856037 Trial NCT00816413 Trial NCT00736450 Trial NCT00679029 Trial NCT00666731 Trial NCT00665457 Trial NCT00625690 Trial NCT00617799 Trial NCT00611351 Trial NCT00607828 Trial NCT00602797 Trial NCT00577798 Trial NCT00569543 Trial NCT00503880 Trial NCT00499083 Trial NCT00496756 Trial NCT00486356 Trial NCT00483561 Trial NCT00483366 Trial NCT00482807 Trial NCT00089024 Trial NCT00082641 Trial NCT00007865 Trial NCT00007852 Trial NCT00006478 Trial NCT00004874 Trial NCT00004198 Trial NCT00004197 Trial NCT00004192 Trial NCT00004112 Patent 7166704 Patent 6680196

Abstract

Description: (Applicant's Description) The Protocol Review and Monitoring System (Scientific Review Committee - SRC) of the UNMC Eppley Cancer Center was formed in 1996. In September of 1997 the Chancellor of UNMC mandated that all cancer-related protocols be formally reviewed and approved by the SRC prior to being approved for accrual by the Institutional Review Board. The SRC also reviews all previously existing active cancer protocols for formal SRC approval prior to receiving renewal approval by the IRB. The SRC performs annual review of all cancer-related protocols. The Committee also reviews changes to investigator initiated or industry sponsored protocols before continued accrual can occur. The SRC has the authority to terminate cancer protocols under specific guidelines. The SRC meets monthly at least ten days prior to the IRB meeting. Expedited SRC review requests are coordinated through the SRC chair. The SRC reviewed 140 cancer-related protocols in 1998. The SRC is committed to peer reviewed clinical cancer research.

View original record on NIH RePORTER →